Physician profile
Gabriela Quintana
NPI 1902577463
$2,284.81
in general payments reported to CMS, 2019-2025
16 companies · $839 in 2025
The $839 reported for 2025 was more than what 89% of General Practice (Registered Nurse) providers received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $193 · 2023: $687 · 2024: $565 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,091.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $508.95 | 2023-2025 | Repatha, Repatha, Otezla |
| Lilly USA, LLC | $418.59 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Exact Sciences Corporation | $313.82 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.32 | 2022-2025 | Jardiance, Synjardy, Tradjenta |
| Novo Nordisk INC | $173.77 | 2023-2025 | Rybelsus, Ozempic |
| Kowa Pharmaceuticals America, INC. | $114.26 | 2025 | Zoryve |
| Pfizer INC. | $107.02 | 2023-2024 | |
| Abbvie INC. | $89.19 | 2025 | |
| Phathom Pharmaceuticals, INC. | $74.13 | 2024-2025 | Voquezna |
| Astrazeneca Pharmaceuticals Lp | $69.65 | 2024 | Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $55.46 | 2022-2023 | |
| Phadia US INC. | $48.55 | 2022-2023 | Immunocap |
| Janssen Pharmaceuticals, INC | $36.79 | 2023 | Xarelto |
| Amneal Pharmaceuticals LLC | $30.55 | 2022-2023 | Unithroid |
| Inspire Medical Systems, INC. | $22.94 | 2024 | Inspire |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $21.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriela Quintana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.